IQVIA HOLDINGS INC. Debt Instrument, Fair Value Disclosure
IQVIA HOLDINGS INC. (IQV) had Debt Instrument, Fair Value Disclosure of $2.00 billion as of 2014-09-30, per its 10-Q filed 2014-10-30.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFairValue · last filed 2014-10-30
- 2014-09-30: Debt Instrument, Fair Value Disclosure $2.00B.
- 2014-06-30: Debt Instrument, Fair Value Disclosure $2.10B.
- 2014-03-31: Debt Instrument, Fair Value Disclosure $2.10B.
- 2013-12-31: Debt Instrument, Fair Value Disclosure $2.10B.
| Period end | Debt Instrument, Fair Value Disclosure |
|---|---|
| 2014-09-30 | $2.00B 10-Q · filed 2014-10-30 |
| 2014-06-30 | $2.10B 10-Q · filed 2014-07-31 |
| 2014-03-31 | $2.10B 10-Q · filed 2014-05-01 |
| 2013-12-31 | $2.10B 10-Q · filed 2014-10-30 |
| 2013-09-30 | $2.10B 10-Q · filed 2013-10-31 |
| 2013-06-30 | $2.10B 10-Q · filed 2013-08-01 |
| 2013-03-31 | $2.50B 10-Q · filed 2013-05-14 |
| 2012-12-31 | $2.50B 10-Q · filed 2013-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |